VistaGen Therapeutics (VTGN) EPS (2011 - 2026)
VistaGen Therapeutics (VTGN) EPS from Mar 31, 2011 to Mar 31, 2026. The TTM VistaGen Therapeutics (VTGN) EPS is -$1.89. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
VistaGen Therapeutics (VTGN) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -6.86% |
| 3 Years | -32.92% |
| 5 Years | -35.47% |
| 10 Years | -9.94% |
| All Time | -3.01% |
Annual EPS change of VistaGen Therapeutics (VTGN)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$1.83 | +9.90% |
| 2025 | -$1.67 | +9.78% |
| 2024 | -$1.52 | -82.18% |
| 2023 | -$8.51 | +17.65% |
| 2022 | -$7.24 | +97.13% |
| 2021 | -$3.67 | -3.89% |
| 2019 | -$3.82 | -55.79% |
| 2018 | -$8.64 | +478.57% |
| 2016 | -$1.49 | -8.40% |
| 2015 | -$1.63 | +64.33% |
| 2014 | -$0.99 | -19.53% |
| 2013 | -$1.23 | +43.59% |
| 2011 | -$0.86 | N/A |
Comparison VistaGen Therapeutics (VTGN) five years EPS CAGR with competitors
VistaGen Therapeutics (VTGN) five years EPS CAGR is -12.57%.